Immune suppression gene on HLA-Bw54-DR4-DRw53 haplotype controls nonresponsiveness in humans to hepatitis B surface antigen via CD8⁺ suppressor T cells

Medicine and Dentistry

• Hepatitis B Antigen 83%
• Gene 50%
• Immunosuppressive Treatment 50%
• Haplotype 33%
• Regulatory T Cell 33%
• Development 16%
• Adult T-Cell Leukemia/Lymphoma 16%
• Monoclonal Antibody 16%
• Immune Response 16%
• Antigen 16%
• Human 16%
• Vaccine 16%
• Immunization 16%
• Liver Disease 16%
• Acquired Immune Deficiency Syndrome 16%
• Hepatitis B Virus 16%
• Gene Linkage Disequilibrium 16%
• Virus Vaccine 16%

Immunology and Microbiology

• HBsAg 83%
• Immunity 50%
• Gene Repression 50%
• Viral Disease 33%
• Haplotype 33%
• Development 16%
• Liver 16%
• Immune Response 16%
• Human 16%
• Antigen 16%
• Vaccine Efficacy 16%
• CD8 16%
• Hepatitis B Virus 16%
• Acquired Immune Deficiency Syndrome 16%
• Virus Vaccine 16%
• Gene Linkage Disequilibrium 16%

Biochemistry, Genetics and Molecular Biology

• T Cell 100%
• Gene Repression 50%
• Haplotype 33%
• HBsAg 33%
• Development 16%
• CD8 16%
• Human 16%
• Immune Response 16%
• Gene Linkage Disequilibrium 16%
• Monoclonal Antibody 16%
• Hepatitis B Virus 16%
• Recombinant DNA 16%